Destiny Pharma Seeks AIM Listing To Advance First-In-Class Antibiotics

 
• By Sten Stovall
  
Doctor holding in hand Antibiotic Resistance
Destiny Pharma IPO To Fund Its XF Antibiotic Platform • Source: Shutterstock

More from Strategy

More from Business